Jump to content

Pseudohypoxia

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Quantumobserver (talk | contribs) at 07:03, 24 December 2013 (Cleanup following Wikipedia:Articles for creation creation (AFCH)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.


Pseudohypoxia refers to increased cytosolic ratio of free NADH to NAD in cells[1] Research has shown that declining NAD+ during aging causes pseudohypoxia, and that raising nuclear NAD+ in old mice reverses pseudohypoxia and metabolic dysfunction, thus reversing the ageing process[2]. It is expected that human NAD trials will begin in 2014 [3]

References

  1. ^ [1] Diabetes Magazine: Hyperglycemic Pseudohypoxia and Diabetic Complications, March 12, 1993
  2. ^ [2] Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging, Cell, Dec 2013
  3. ^ [3]Guardian Newspaper - Online, Dec 2013